These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20073404)

  • 21. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia.
    Fine LG; Bandyopadhay D; Norman JT
    Kidney Int Suppl; 2000 Apr; 75():S22-6. PubMed ID: 10828757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney.
    Song YR; You SJ; Lee YM; Chin HJ; Chae DW; Oh YK; Joo KW; Han JS; Na KY
    Nephrol Dial Transplant; 2010 Jan; 25(1):77-85. PubMed ID: 19737871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular responses to hypoxia after renal segmental infarction.
    Rosenberger C; Griethe W; Gruber G; Wiesener M; Frei U; Bachmann S; Eckardt KU
    Kidney Int; 2003 Sep; 64(3):874-86. PubMed ID: 12911537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of tubular cells in progressive renal disease.
    van Kooten C; Langers AM; Bruijn JA; Daha MR
    Kidney Blood Press Res; 1999; 22(1-2):53-61. PubMed ID: 10352408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease.
    Tanaka T; Nangaku M
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):43-50. PubMed ID: 19779337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of chronic renal disease--an update.
    Yazdani I
    J Pak Med Assoc; 1994 Dec; 44(12):290-4. PubMed ID: 7861589
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythropoietin and renoprotection.
    Bahlmann FH; Fliser D
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):15-20. PubMed ID: 19077684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic kidney disease: the global challenge.
    Meguid El Nahas A; Bello AK
    Lancet; 2005 Jan 22-28; 365(9456):331-40. PubMed ID: 15664230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease.
    Khan S; Cleveland RP; Koch CJ; Schelling JR
    Lab Invest; 1999 Sep; 79(9):1089-99. PubMed ID: 10496527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIF-1alpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart.
    Maloyan A; Eli-Berchoer L; Semenza GL; Gerstenblith G; Stern MD; Horowitz M
    Physiol Genomics; 2005 Sep; 23(1):79-88. PubMed ID: 16046617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy.
    Sun D; Feng J; Dai C; Sun L; Jin T; Ma J; Wang L
    Am J Nephrol; 2006; 26(4):363-71. PubMed ID: 16873992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiology and pathophysiology of heme: implications for kidney disease.
    Tracz MJ; Alam J; Nath KA
    J Am Soc Nephrol; 2007 Feb; 18(2):414-20. PubMed ID: 17229906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy.
    Lenderink AM; Liegel K; Ljubanović D; Coleman KE; Gilkeson GS; Holers VM; Thurman JM
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F555-64. PubMed ID: 17522263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increased expression of plasminogen activator inhibitor-1 in hypoxic renal injury and its pathological significance in progression of advanced renal disease].
    Kimura H
    Rinsho Byori; 2005 Aug; 53(8):749-58. PubMed ID: 16190362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of tubulointerstitial inflammation in the progression of chronic renal failure.
    Rodríguez-Iturbe B; García García G
    Nephron Clin Pract; 2010; 116(2):c81-8. PubMed ID: 20502043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury.
    Cheng S; Pollock AS; Mahimkar R; Olson JL; Lovett DH
    FASEB J; 2006 Sep; 20(11):1898-900. PubMed ID: 16891619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal tubulointerstitial fibrosis. New thoughts on its development and progression.
    O'Donnell MP
    Postgrad Med; 2000 Jul; 108(1):159-62, 165, 171-2. PubMed ID: 10914125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia.
    Tanaka T; Yamaguchi J; Higashijima Y; Nangaku M
    FASEB J; 2013 Oct; 27(10):4059-75. PubMed ID: 23792300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasticity of kidney cells: role in kidney remodeling and scarring.
    El-Nahas AM
    Kidney Int; 2003 Nov; 64(5):1553-63. PubMed ID: 14531787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.